Literature DB >> 3913771

Drug interactions with methotrexate.

W E Evans, M L Christensen.   

Abstract

General mechanisms of drug interactions are reviewed, as well as the effects of various drugs on the absorption, distribution, protein binding, eliminations and cellular transport of methotrexate. Published studies demonstrate that prior or concomitant administration of other drugs can alter the efficacy and toxicity of methotrexate. Nonabsorbable antibiotics can decrease methotrexate absorption. Nephrotoxic drugs can decrease methotrexate renal clearance. Salicylates and probenecid may decrease the plasma protein binding and renal tubular secretion of methotrexate. However, the clinical significance of many of these drug interactions is not known or has not been substantiated by extensive clinical observations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3913771

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  14 in total

1.  [New immunosuppressive agents for treating psoriasis].

Authors:  S Ortiz-Urda; K Rappersberger
Journal:  Hautarzt       Date:  2003-02-18       Impact factor: 0.751

Review 2.  Protein binding drug displacement interactions fact or fiction?

Authors:  J J MacKichan
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

3.  Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up.

Authors:  A A Drosos; D Psychos; A P Andonopoulos; S Stefanaki-Nikou; E B Tsianos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 4.  [Is methotrexate nephrotoxic? Dose-dependency, comorbidities and comedication].

Authors:  U Erdbrügger; K de Groot
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

5.  Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate.

Authors:  Courtney S Watts; Joseph N Sciasci; Jennifer L Pauley; John C Panetta; Deqing Pei; Cheng Cheng; Caroline M Christensen; Torben S Mikkelsen; Ching-Hon Pui; Sima Jeha; Mary V Relling
Journal:  J Pediatr Hematol Oncol       Date:  2016-08       Impact factor: 1.289

Review 6.  Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Authors:  Gil Yosipovitch; Mark B Y Tang
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.

Authors:  M Joerger; A D R Huitema; S Krähenbühl; J H M Schellens; T Cerny; M Reni; E Zucca; F Cavalli; A J M Ferreri
Journal:  Br J Cancer       Date:  2010-02-02       Impact factor: 7.640

Review 8.  The practical use of methotrexate in psoriasis.

Authors:  J P Tung; H I Maibach
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

Review 9.  Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?

Authors:  Alexandros Drosos
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Antineoplastic agents. Drug interactions of clinical significance.

Authors:  E van Meerten; J Verweij; J H Schellens
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.